Second Drug Now Approved for Treating Alzheimer's Patients

Treatment options for patients with Alzheimer’s disease just took a big leap forward with the approval of a second drug, donanemab, that helps patients with early symptomatic Alzheimer’s disease maintain function and quality of life.

As opções de tratamento para pacientes com doença de Alzheimer acabam de dar um grande salto com a aprovação de um segundo medicamento, o donanemab, que ajuda os pacientes com doença de Alzheimer sintomática inicial a manter a função e a qualidade de vida.